Results 171 to 180 of about 63,533 (294)

Risk of Crohn's disease in children presenting with perianal abscess and fistula increases with age: A multicenter study

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1226-1232, May 2026.
Abstract Objectives Perianal abscesses (PA) and fistulas‐in‐ano (FIA) are frequently diagnosed in children and may be presenting symptoms of Crohn's disease (CD). The association between age at presentation of PA/FIA and the risk of subsequent CD development is largely unknown.
Mariëlle Roskam, Thomas Dierikx, Sanne Hulsmann, Jesse Lemmen, Vanessa Leijdekkers, Joanna Luttikhold, Frank Garssen, Mich Dunker, Jarmila van der Bilt, Justin de Jong, Ernst van Heurn, Nanne de Boer, Roel Bakx, Tim de Meij   +13 more
wiley   +1 more source

Ileal Crohn's Disease. A case report [PDF]

Anales de la Facultad de Ciencias Médicas (Asunción), 2017
J Ortiz Villalba, H Macchi Salim, B Di Martino Ortiz   +2 more
openaire   +1 more source

Severe allergic reaction to ustekinumab reinitiation in a pediatric patient with Crohn's disease: A case report

JPGN Reports, Volume 7, Issue 2, Page 306-308, May 2026.
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling, Shauna Schroeder, Brad Pasternak   +2 more
wiley   +1 more source

<i>Bifidobacterium animalis</i> subsp. <i>animalis</i> GY007 Mitigates High Fluoride Exposure-Induced Ileal Injury and Restores the Ileal Microbiota-Metabolome Imbalances. [PDF]

Biology (Basel)
Chen Y, Zeng Y, Jing B, Zeng D, Ni X.
europepmc   +1 more source

Menetrier's: A pediatric chronic state of disease with a possible heritable form

JPGN Reports, Volume 7, Issue 2, Page 259-261, May 2026.
Abstract Menetrier's disease (MD) is a rare, typically transient, hypertrophic gastropathy with under 1000 adult cases and 50 pediatric cases known worldwide. Pediatric cases most often present with an infectious etiology. We present a case of a teenage male expressing a chronic state of disease without infectious origin.
MariaElena Terzis, Anna Furr, Julia Fritz   +2 more
wiley   +1 more source

Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after ureteral stent removal following radical cystectomy. [PDF]

World J Urol
Kitano H, Watanabe E, Tadera K, Nakano Y, Tasaka S, Yukihiro K, Okazaki M, Nomura N, Hatayama T, Shikuma H, Iwane K, Tasaka R, Kohada Y, Takemoto K, Miyamoto S, Naito M, Kobatake K, Sekino Y, Goto K, Goriki A, Hieda K, Hayashi T, Kashiyama S, Ohge H, Hinata N.   +24 more
europepmc   +1 more source

Benralizumab for anti‐tumor necrosis factor‐associated eosinophilic gastrointestinal disease in a child with ileal Crohn's: A case report

JPGN Reports, Volume 7, Issue 2, Page 312-314, May 2026.
Abstract Crohn's disease (CD) and eosinophilic gastrointestinal diseases (EGIDs) are distinct inflammatory entities, but eosinophilic disease may emerge as a paradoxical immune complication of anti–tumor necrosis factor therapy. We report a 12‐year‐old boy with terminal ileal CD who developed severe eosinophilic gastritis and ileitis, peripheral ...
Jonathan Dudzik, Alberto Pinzon‐Charry, Peter Lewindon, Fariha Balouch   +3 more
wiley   +1 more source

Push Enteroscopic Jejunal and Ileoscopic Delivery of Fecomicrobiota Transplantation (FMT) for Treatment of <i>Clostridioides difficile</i> Enteritis in a Patient With a Total Colectomy and Ileal Pouch-Anal Anastomosis (IPAA): A Case Report. [PDF]

JGH Open
Tan Z, Young E, Rajagopalan A.
europepmc   +1 more source

IMPROVING CONSPICUITY OF THE CANINE GASTROINTESTINAL WALL USING DUAL PHASE CONTRAST-ENHANCED COMPUTED TOMOGRAPHY: A RETROSPECTIVE CROSS-SECTIONAL STUDY [PDF]

, 2017
Balthazar, Bonekamp, Choi, Del Campo, Delorme, Evans, Fields, Gaschen, Gladwin, Hoey, Jeon, Kleinschmidt, Lee, O'Brien, O'Neill, Penninck, Ramos-Andrade, Reis, Shales, Shanaman, Shanaman, Simpson, Sutherland-Smith, Terragni, Wittenberg   +24 more
core   +2 more sources

Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
ABSTRACT Background Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos   +51 more
wiley   +1 more source